Li et al. reported that leptin treatment increased the expression of a variety of cytokines in TAMs to promote the migration and invasion of BC cells; IL-18 regulation by the NF-κB/NF-κB1 signaling pathway was found to be the most significant change induced by this treatment [167]. The gene discussed is NFKB1; the disease is breast cancer.